Article Text
Abstract
This article examines a key ethical concern that has arisen in the work of the international research consortium GenoMEL (http://www.genomel.org) and that has relevance to all genetic research in humans. The question is whether it is ethical to deny research participants the opportunity to receive individualised genetic results obtained from the biological samples they provide. Where those results are of clinical importance, a “respect for persons” requirement would make the offering of those results imperative. However, where those results are of uncertain clinical value, the picture is less clear. This paper argues that researchers may not be ethically obliged to offer such results to their participants, because of competing ethical demands.
Statistics from Altmetric.com
Footnotes
Competing interests: None.
Funding: The author is employed by the coordinator of GenoMEL, the University of Leeds, as a project manager.
Provenance and peer review: Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Duty to disclose what? Querying the putative obligation to return research results to participants
- Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- What does ‘respect for persons’ require? Attitudes and reported practices of genetics researchers in informing research participants about research
- Acknowledging awareness: informing families of individual research results for patients in the vegetative state
- The return of individual research findings in paediatric genetic research
- Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance
- Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
- Developing an ethics framework for living donor transplantation
- Issues of consent and feedback in a genetic epidemiological study of women with breast cancer